Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| PDPK1 | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 33.90 | Evidence |
|
||||
| PDPK1 | MAP2K2 | MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki | 33.90 | Evidence | |||||
| PDPK1 | FRS3 | FRS3: Fibroblast growth factor receptor substrate 3 | 20.50 | Evidence | |||||
| PDPK1 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 20.50 | Evidence | |||||
| PDPK1 | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 20.50 | Evidence | |||||
| PDPK1 | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 19.70 | Evidence |
|
||||
| PDPK1 | SNCA | SNCA, NACP, PARK1: Alpha-synuclein | 19.70 | Evidence | |||||
| PDPK1 | NEK3 | NEK3: Serine/threonine-protein kinase Nek3 | 19.70 | Evidence | |||||
| PDPK1 | MAP2K1 | MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 | 17.60 | Evidence | |||||
| PDPK1 | RPS6KA5 | RPS6KA5, MSK1: Ribosomal protein S6 kinase alpha-5 | 17.60 | Evidence | |||||
| PDPK1 | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 17.60 | Evidence | |||||
| PDPK1 | DUSP6 | DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 | 17.60 | Evidence | |||||
| PDPK1 | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 17.60 | Evidence | |||||
| PDPK1 | DUSP1 | DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 | 17.60 | Evidence | |||||
| PDPK1 | WNK4 | WNK4, PRKWNK4: Serine/threonine-protein kinase WNK4 | 17.60 | Evidence | |||||
| PDPK1 | TAOK3 | TAOK3, DPK, JIK, KDS, MAP3K18: Serine/threonine-protein kinase TAO3 | 17.60 | Evidence | |||||
| PDPK1 | MSN | MSN: Moesin | 17.60 | Evidence | |||||
| PDPK1 | PRKD1 | PRKD1, PKD, PKD1, PRKCM: Serine/threonine-protein kinase D1 | 17.60 | Evidence | |||||
| PDPK1 | MKNK1 | MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 | 17.60 | Evidence | |||||
| PDPK1 | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 17.60 | Evidence | |||||
| PDPK1 | PIK3CB | PIK3CB, PIK3C1: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit | 17.60 | Evidence | |||||
| PDPK1 | RHOB | RHOB, ARH6, ARHB: Rho-related GTP-binding protein RhoB precursor | 17.60 | Evidence | |||||
| PDPK1 | TIAM1 | TIAM1: T-lymphoma invasion and metastasis-inducing protein 1 | 17.60 | Evidence | |||||
| PDPK1 | RPS6KA2 | RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 | 17.60 | Evidence | |||||
| PDPK1 | PARD6A | PARD6A, PAR6A: Partitioning defective 6 homolog alpha | 17.60 | Evidence | |||||
| PDPK1 | MCF2 | MCF2, DBL: Proto-oncogene DBL | 15.00 | Evidence | |||||
| PDPK1 | HMGN1 | HMGN1, HMG14: Non-histone chromosomal protein HMG-14 | 15.00 | Evidence | |||||
| PDPK1 | HMGN2 | HMGN2, HMG17: Non-histone chromosomal protein HMG-17 | 15.00 | Evidence | |||||
| PDPK1 | GSK3A | GSK3A: Glycogen synthase kinase-3 alpha | 13.40 | Evidence | |||||
| PDPK1 | STMN1 | STMN1, LAP18, OP18: Stathmin | 13.40 | Evidence | |||||
| PDPK1 | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 13.40 | Evidence | |||||
| PDPK1 | CSK | CSK: Tyrosine-protein kinase CSK | 13.40 | Evidence | |||||
| PDPK1 | DOK1 | DOK1: Docking protein 1 | 13.40 | Evidence | |||||
| PDPK1 | BRAF | BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase | 13.40 | Evidence | |||||
| PDPK1 | RRAD | RRAD, RAD: GTP-binding protein RAD | 13.40 | Evidence | |||||
| PDPK1 | EEF2K | EEF2K: Elongation factor 2 kinase | 13.40 | Evidence | |||||
| PDPK1 | STMN2 | STMN2, SCG10, SCGN10: Stathmin-2 | 13.40 | Evidence | |||||
| PDPK1 | FER | FER, TYK3: Proto-oncogene tyrosine-protein kinase FER | 13.40 | Evidence | |||||
| PDPK1 | FRK | FRK, PTK5, RAK: Tyrosine-protein kinase FRK | 13.40 | Evidence | |||||
| PDPK1 | RAP1A | RAP1A, KREV1: Ras-related protein Rap-1A precursor | 13.40 | Evidence | |||||
| PDPK1 | TGFBR2 | TGFBR2: TGF-beta receptor type-2 precursor | 11.60 | Evidence | |||||
| PDPK1 | SEMA5A | SEMA5A, SEMAF: Semaphorin-5A precursor | 11.60 | Evidence | |||||
| PDPK1 | SALF | GTF2A1L, ALF, GTF2A1LF: TFIIA-alpha and beta-like factor | 9.96 | Evidence | |||||
| PDPK1 | SYTL4 | Endocrine transmitter regulatory protein | 9.96 | Evidence | |||||
| PDPK1 | H1FX | H1FX: Histone H1x | 9.96 | Evidence | |||||
| PDPK1 | GHR | GHR: Growth hormone receptor precursor | 9.92 | Evidence | |||||
| PDPK1 | GABRR1 | N/A | 9.92 | Evidence | |||||
| PDPK1 | PTPRR | PTPRR, ECPTP, PTPRQ: Receptor-type tyrosine-protein phosphatase R precursor | 9.92 | Evidence | |||||
| PDPK1 | HSF1 | HSF1, HSTF1: Heat shock factor protein 1 | 8.92 | Evidence | |||||
| PDPK1 | JUN | JUN: Transcription factor AP-1 | 8.92 | Evidence | |||||
| PDPK1 | TLN1 | TLN1: Uncharacterized protein TLN1 | 8.92 | Evidence | |||||
| PDPK1 | MIP | MIP, AQP0: Lens fiber major intrinsic protein | 8.89 | Evidence | |||||
| PDPK1 | CENTA1 | CENTA1: Centaurin-alpha 1 | 8.22 | Evidence | |||||
| PDPK1 | PDGFA | PDGFA, PDGF1: Platelet-derived growth factor A chain precursor | 8.22 | Evidence | |||||
| PDPK1 | ETV1 | ETV1, ER81: ETS translocation variant 1 | 7.59 | Evidence | |||||
| PDPK1 | NOS1 | NOS1: Nitric-oxide synthase, brain | 7.59 | Evidence | |||||
| PDPK1 | ELF1 | ELF1: ETS-related transcription factor Elf-1 | 7.59 | Evidence | |||||
| PDPK1 | CHAT | CHAT: Choline O-acetyltransferase | 7.36 | Evidence | |||||
| PDPK1 | CCNB1 | Cyclin B1 | 6.82 | Evidence | |||||
| PDPK1 | PRKCA | PRKCA, PKCA, PRKACA: Protein kinase C alpha type | 6.82 | Evidence | |||||
| PDPK1 | PRKCG | PRKCG, PKCG: Protein kinase C gamma type | 6.82 | Evidence | |||||
| PDPK1 | PRKCQ | PRKCQ, PRKCT: Protein kinase C theta type | 6.82 | Evidence | |||||
| PDPK1 | SGK2 | SGK2: Serine/threonine-protein kinase Sgk2 | 6.82 | Evidence |
|
||||
| PDPK1 | CDK2 | CDK2: Cell division protein kinase 2 | 6.82 | Evidence | |||||
| PDPK1 | PHC2 | PHC2, EDR2, PH2: Polyhomeotic-like protein 2 | 6.80 | Evidence | |||||
| PDPK1 | TRAP1 | TRAP1, HSP75: Heat shock protein 75 kDa, mitochondrial precursor | 6.80 | Evidence | |||||
| PDPK1 | HIST1H1B | HIST1H1B, H1F5: Histone H1.5 | 6.80 | Evidence | |||||
| PDPK1 | LCP1 | LCP1, PLS2: Plastin-2 | 6.80 | Evidence | |||||
| PDPK1 | FER1L3 | FER1L3, KIAA1207, MYOF: Myoferlin | 6.80 | Evidence | |||||
| PDPK1 | CGA | CGA: Glycoprotein hormones alpha chain precursor | 6.26 | Evidence | |||||
| PDPK1 | GDF15 | GDF15, MIC1, PDF, PLAB, PTGFB: Growth/differentiation factor 15 precursor | 6.26 | Evidence | |||||
| PDPK1 | KRT1 | KRT1, KRTA: Keratin, type II cytoskeletal 1 | 6.24 | Evidence | |||||
| PDPK1 | PPP1R1B | PPP1R1B, DARPP32: Protein phosphatase 1 regulatory subunit 1B | 6.14 | Evidence | |||||
| PDPK1 | GJA1 | GJA1, GJAL: Gap junction alpha-1 protein | 6.14 | Evidence | |||||
| PDPK1 | RAB1B | RAB1B: Ras-related protein Rab-1B | 5.96 | Evidence | |||||
| PDPK1 | FADD | FADD, MORT1: Protein FADD | 5.87 | Evidence | |||||
| PDPK1 | TRPV1 | TRPV1: Vanilloid receptor variant TRPV1b | 5.87 | Evidence | |||||
| PDPK1 | PSMC2 | PSMC2, MSS1: 26S protease regulatory subunit 7 | 5.73 | Evidence | |||||
| PDPK1 | RPS6KA3 | RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 | 5.61 | Evidence |
|
||||
| PDPK1 | PFKFB2 | PFKFB2: 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 | 5.61 | Evidence | |||||
| PDPK1 | PPP1R14A | PPP1R14A, CPI17, PPP1INL: Protein phosphatase 1 regulatory subunit 14A | 5.50 | Evidence | |||||
| PDPK1 | CDK3 | CDK3: Cell division protein kinase 3 | 5.48 | Evidence | |||||
| PDPK1 | CCNB2 | CCNB2: G2/mitotic-specific cyclin-B2 | 5.48 | Evidence | |||||
| PDPK1 | GRIN1 | GRIN1, NMDAR1: Glutamate [NMDA] receptor subunit zeta-1 precursor | 5.26 | Evidence | |||||
| PDPK1 | GNA13 | GNA13: Guanine nucleotide-binding protein alpha-13 subunit | 5.26 | Evidence | |||||
| PDPK1 | SLC4A3 | SLC4A3, AE3: Anion exchange protein 3 | 4.78 | Evidence | |||||
| PDPK1 | GJA5 | GJA5: Gap junction alpha-5 protein | 4.68 | Evidence | |||||
| PDPK1 | GJB1 | GJB1, CX32: Gap junction beta-1 protein | 4.68 | Evidence | |||||
| PDPK1 | TPH1 | N/A | 4.68 | Evidence | |||||
| PDPK1 | RAP1GA1 | N/A | 4.48 | Evidence | |||||
| PDPK1 | ATP2B1 | N/A | 4.48 | Evidence | |||||
| PDPK1 | MAFG | MAFG: Transcription factor MafG | 4.26 | Evidence | |||||
| PDPK1 | IKBKE | IKBKE, IKKE, IKKI, KIAA0151: Inhibitor of nuclear factor kappa-B kinase subunit | 4.19 | Evidence | |||||
| PDPK1 | TH | TH, TYH: Tyrosine 3-monooxygenase | 4.19 | Evidence | |||||
| PDPK1 | CDC37 | CDC37: Hsp90 co-chaperone Cdc37 | 4.19 | Evidence | |||||
| PDPK1 | CFTR | CFTR: Cystic fibrosis transmembrane conductance regulator ATP-binding cassette s | 4.03 | Evidence | |||||
| PDPK1 | GRM3 | GRM3, GPRC1C, MGLUR3: Metabotropic glutamate receptor 3 precursor | 4.01 | Evidence | |||||
| PDPK1 | MYCBP2 | MYCBP2, KIAA0916, PAM: Probable E3 ubiquitin-protein ligase MYCBP2 | 4.01 | Evidence | |||||
| PDPK1 | GRIA1 | GRIA1, GLUH1, GLUR1: Glutamate receptor 1 precursor | 4.01 | Evidence | |||||
| PDPK1 | GRIA4 | GRIA4, GLUR4: Glutamate receptor 4 precursor | 4.01 | Evidence | |||||
| PDPK1 | SGK3 | SGK3, SGK2, SGKL: Serine/threonine-protein kinase Sgk3 | 3.65 | Evidence |
|
||||
| PDPK1 | PRKACA | PRKACA, PKACA: cAMP-dependent protein kinase, alpha-catalytic subunit | 3.65 | Evidence |
|
||||
| PDPK1 | SGK | SGK, SGK1: Serine/threonine-protein kinase Sgk1 | 3.65 | Evidence |
|
||||
| PDPK1 | GAD2 | GAD2, GAD65: Glutamate decarboxylase 2 | 3.61 | Evidence | |||||
| PDPK1 | OPRD1 | OPRD1, OPRD: Delta-type opioid receptor | 3.61 | Evidence | |||||
| PDPK1 | AFAP | AFAP1, AFAP: Actin filament-associated protein 1 | 3.34 | Evidence | |||||
| PDPK1 | KRT18 | KRT18: Uncharacterized protein KRT18 | 3.34 | Evidence | |||||
| PDPK1 | GNB2L1 | Lung cancer oncogene 7 | 3.34 | Evidence | |||||
| PDPK1 | NCF4 | N/A | 3.34 | Evidence | |||||
| PDPK1 | ZNF579 | ZNF579: Zinc finger protein 579 | 3.34 | Evidence | |||||
| PDPK1 | ZYX | ZYX: Zyxin | 3.34 | Evidence | |||||
| PDPK1 | SLC2A2 | SLC2A2, GLUT2: Solute carrier family 2, facilitated glucose transporter member 2 | 3.26 | Evidence | |||||
| PDPK1 | ARHGEF1 | ARHGEF1: Rho guanine nucleotide exchange factor 1 | 3.18 | Evidence | |||||
| PDPK1 | PLEKHA4 | PLEKHA4, PEPP1: Pleckstrin homology domain-containing family A member 4 | 3.18 | Evidence | |||||
| PDPK1 | RYR2 | RYR2: Ryanodine receptor 2 | 3.07 | Evidence | |||||
| PDPK1 | IL18 | IL18, IGIF, IL1F4: Interleukin-18 precursor | 3.07 | Evidence | |||||
| PDPK1 | TCEA1 | N/A | 2.99 | Evidence | |||||
| PDPK1 | NR4A2 | NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 | 2.99 | Evidence | |||||
| PDPK1 | PPID | PPID, CYP40, CYPD: 40 kDa peptidyl-prolyl cis-trans isomerase | 2.99 | Evidence | |||||
| PDPK1 | SMAD2 | SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 | 2.99 | Evidence | |||||
| PDPK1 | BUB3 | BUB3: Mitotic checkpoint protein BUB3 | 2.99 | Evidence | |||||
| PDPK1 | PARD6G | PARD6G, PAR6G: Partitioning defective 6 homolog gamma | 2.85 | Evidence | |||||
| PDPK1 | GRIN2B | GRIN2B, NMDAR2B: Glutamate [NMDA] receptor subunit epsilon-2 precursor | 2.75 | Evidence | |||||
| PDPK1 | HMGCR | HMGCR: 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 2.75 | Evidence | |||||
| PDPK1 | KCNA2 | KCNA2: Potassium voltage-gated channel subfamily A member 2 | 2.75 | Evidence | |||||
| PDPK1 | LIPE | LIPE: Hormone-sensitive lipase | 2.75 | Evidence | |||||
| PDPK1 | RYR1 | 2.75 | Evidence | ||||||
| PDPK1 | SCRIB | SCRIB, CRIB1, KIAA0147, LAP4, SCRB1, VARTUL: Protein LAP4 | 2.54 | Evidence | |||||
| PDPK1 | GFAP | GFAP: Glial fibrillary acidic protein | 2.54 | Evidence | |||||
| PDPK1 | TLE3 | TLE3, KIAA1547: Transducin-like enhancer protein 3 | 2.54 | Evidence | |||||
| PDPK1 | DKFZp434K1815 | DKFZp434K1815, hCG_1736780: Putative uncharacterized protein DKFZp434K1815 | 2.54 | Evidence | |||||
| PDPK1 | ZCCHC3 | ZCCHC3, C20orf99: Zinc finger CCHC domain-containing protein 3 | 2.54 | Evidence | |||||
| PDPK1 | PTBP1 | PTBP1: Polypyrimidine tract binding protein 1 | 2.54 | Evidence | |||||
| PDPK1 | PDLIM1 | PDLIM1, CLIM1, CLP36: PDZ and LIM domain protein 1 | 2.54 | Evidence | |||||
| PDPK1 | TERF2IP | TERF2IP, RAP1, PP8000: Telomeric repeat-binding factor 2-interacting protein 1 | 2.54 | Evidence | |||||
| PDPK1 | SLC9A3R2 | SLC9A3R2: SLC9A3R2 protein (Fragment) | 2.54 | Evidence |
|
||||
| PDPK1 | AANAT | AANAT, SNAT: Serotonin N-acetyltransferase | 2.54 | Evidence | |||||
| PDPK1 | PTPN7 | N/A | 2.54 | Evidence | |||||
| PDPK1 | NR3C1 | NR3C1, GRL: Glucocorticoid receptor | 2.54 | Evidence | |||||
| PDPK1 | PTPRN2 | PTPRN2: Receptor-type tyrosine-protein phosphatase N2 precursor | 2.43 | Evidence | |||||
| PDPK1 | MAP3K2 | MAP3K2, MAPKKK2, MEKK2: Mitogen-activated protein kinase kinase kinase 2 | 2.43 | Evidence | |||||
| PDPK1 | EPM2A | EPM2A: Laforin | 2.43 | Evidence | |||||
| PDPK1 | HAND1 | HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 | 2.28 | Evidence | |||||
| PDPK1 | DNAJC7 | DNAJC7, TPR2, TTC2: DnaJ homolog subfamily C member 7 | 2.28 | Evidence | |||||
| PDPK1 | SPAST | SPAST, KIAA1083, SPG4: Spastin | 2.28 | Evidence | |||||
| PDPK1 | FLJ40432 | FLJ40432, hCG_2036624: CDNA FLJ40432 fis, clone TESTI2039227 | 2.28 | Evidence | |||||
| PDPK1 | SNRK | SNRK, KIAA0096, SNFRK: SNF-related serine/threonine-protein kinase | 2.28 | Evidence | |||||
| PDPK1 | KIF3A | KIF3A, KIF3: Kinesin-like protein KIF3A | 2.28 | Evidence | |||||
| PDPK1 | GSK3B | N/A | 2.28 | Evidence | |||||
| PDPK1 | STAG2 | STAG2, SA2: Cohesin subunit SA-2 | 2.28 | Evidence | |||||
| PDPK1 | PPP2CA | PPP2CA: Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform | 2.28 | Evidence | |||||
| PDPK1 | ELAVL1 | ELAVL1, HUR: ELAV-like protein 1 | 2.28 | Evidence | |||||
| PDPK1 | CETN1 | CETN1, CEN1, CETN: Centrin-1 | 2.28 | Evidence | |||||
| PDPK1 | WRN | WRN, RECQ3, RECQL2: Werner syndrome ATP-dependent helicase | 2.28 | Evidence | |||||
| PDPK1 | CAMKK1 | N/A | 2.28 | Evidence | |||||
| PDPK1 | ACIN1 | ACIN1, ACINUS, KIAA0670: Apoptotic chromatin condensation inducer in the nucleus | 2.28 | Evidence | |||||
| PDPK1 | SFRS5 | SFRS5, HRS, SRP40: Splicing factor, arginine/serine-rich 5 | 2.28 | Evidence | |||||
| PDPK1 | LRRC7 | LRRC7, KIAA1365, LAP1: Leucine-rich repeat-containing protein 7 | 2.28 | Evidence | |||||
| PDPK1 | BAZ2A | BAZ2A, KIAA0314, TIP5: Bromodomain adjacent to zinc finger domain protein 2A | 2.28 | Evidence | |||||
| PDPK1 | FRG1 | FRG1: Protein FRG1 | 2.28 | Evidence | |||||
| PDPK1 | SATB1 | SATB1: DNA-binding protein SATB1 | 2.28 | Evidence | |||||
| PDPK1 | KLF1 | KLF1, EKLF: Krueppel-like factor 1 | 2.28 | Evidence | |||||
| PDPK1 | PPP1R9B | PPP1R9B, PPP1R6: Neurabin-2 | 2.28 | Evidence | |||||
| PDPK1 | ZNF224 | ZNF224, BMZF2, KOX22, ZNF233, ZNF255, ZNF27: Zinc finger protein 224 | 2.28 | Evidence | |||||
| PDPK1 | EEF1A1 | EEF1A1: Elongation factor 1-alpha | 2.28 | Evidence | |||||
| PDPK1 | DMXL2 | DMXL2, KIAA0856: DmX-like protein 2 | 2.28 | Evidence | |||||
| PDPK1 | HNRPUL1 | HNRPUL1, E1BAP5: Heterogeneous nuclear ribonucleoprotein U-like protein 1 | 2.28 | Evidence | |||||
| PDPK1 | ARID1A | ARID1A, C1orf4, OSA1, SMARCF1: AT-rich interactive domain-containing protein 1A | 2.28 | Evidence | |||||
| PDPK1 | EIF3S8 | EIF3S8: Eukaryotic translation initiation factor 3 subunit 8 | 2.28 | Evidence | |||||
| PDPK1 | KIAA0664 | KIAA0664: Putative eukaryotic translation initiation factor 3 subunit | 2.28 | Evidence | |||||
| PDPK1 | APC | N/A | 2.28 | Evidence | |||||
| PDPK1 | PDE4B | PDE4B, DPDE4: cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 2.28 | Evidence | |||||
| PDPK1 | DUSP10 | DUSP10, MKP5: Dual specificity protein phosphatase 10 | 2.17 | Evidence | |||||
| PDPK1 | DUSP4 | DUSP4, MKP2, VH2: Dual specificity protein phosphatase 4 | 2.17 | Evidence | |||||
| PDPK1 | YWHAE | YWHAE: 14-3-3 protein epsilon | 2.15 | Evidence | |||||
| PDPK1 | HSP90AA1 | Hsp89-alpha-delta-N | 1.84 | Evidence |
|
||||
| PDPK1 | EIF5 | EIF5: Eukaryotic translation initiation factor 5 | 1.79 | Evidence | |||||
| PDPK1 | ITPKA | ITPKA: Inositol-trisphosphate 3-kinase A | 1.79 | Evidence | |||||
| PDPK1 | PDC | PDC: Phosducin | 1.79 | Evidence | |||||
| PDPK1 | ARFGEF2 | ARFGEF2, ARFGEP2, BIG2: Brefeldin A-inhibited guanine nucleotide-exchange protei | 1.53 | Evidence | |||||
| PDPK1 | PTAFR | PTAFR, PAFR: Platelet-activating factor receptor | 1.30 | Evidence | |||||
| PDPK1 | KCNJ1 | KCNJ1, ROMK1: ATP-sensitive inward rectifier potassium channel 1 | 1.30 | Evidence | |||||
| PDPK1 | MC4R | MC4R: Melanocortin receptor 4 | 1.30 | Evidence | |||||
| PDPK1 | PRKAR1A | PRKAR1A, PKR1, PRKAR1, TSE1: cAMP-dependent protein kinase type I-alpha regulato | 1.27 | Evidence | |||||
| PDPK1 | PRKAR2A | PRKAR2A, PKR2, PRKAR2: cAMP-dependent protein kinase type II-alpha regulatory su | 1.27 | Evidence | |||||
| PDPK1 | KCNJ12 | KCNJ12, IRK2, KCNJN1: ATP-sensitive inward rectifier potassium channel 12 | 1.16 | Evidence | |||||
| PDPK1 | PRKCB1 | N/A | 1.15 | Evidence |
|
||||
| PDPK1 | NUP98 | N/A | 1.15 | Evidence | |||||
| PDPK1 | ZNF174 | ZNF174, ZSCAN8: Zinc finger protein 174 | 1.13 | Evidence | |||||
| PDPK1 | ZNF24 | ZNF24, KOX17, ZNF191, ZSCAN3: Zinc finger protein 24 | 1.13 | Evidence | |||||
| PDPK1 | PRKCH | PRKCH, PKCL, PRKCL: Protein kinase C eta type | 1.10 | Evidence | |||||